TITLE

GnRH AGONIST AND ANTAGONIST: HOW TO OPTIMIZE THEIR USE IN OVARIAN STIMULATION

AUTHOR(S)
Leondires, M.
PUB. DATE
November 2010
SOURCE
Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2010 Supplement 1, Vol. 21 Issue S1, pS9
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the lecture "GnRH Agonist and Antagonist: How to Optimize Their Use in Ovarian Stimulation" by M. Leondires is presented.
ACCESSION #
67657441

 

Related Articles

  • Benefits of luteinizing hormone activity in ovarian stimulation for IVF. Venetis, C. A; Kolibianakis, E. M.; Tarlatzi, T. B.; Tarlatzis, B. C. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;2009 Supplement 2, Vol. 18 Issue S2, pS31 

    Knowledge of the physiology of folliculogenesis has led to a better understanding of the role of LH activity in this process. This role has been investigated in the setting of ovarian stimulation and several treatment modalities have been proposed. LH activity can be provided in the forms of:...

  • An OHSS-Free Clinic by segmentation of IVF treatment. Devroey, Paul; Polyzos, Nikolaos P.; Blockeel, Christophe // Human Reproduction;Oct2011, Vol. 26 Issue 10, p2593 

    Published data indicate a significant increase in ovarian hyperstimulation syndrome globally. The occurrence of approximately three maternal deaths per 100 000 stimulated women has been reported, and extrapolation of these figures to a global situation would give an impressive number. The...

  • GnRH Combined with Luteal Phase Estradiol Comparable to GnRH.  // Fertility Weekly;11/12/2007, p8 

    The article reports on the results of a study conducted in Brazil that addressed the efficacy of combining luteinizing hormone releasing hormone (GnRH) with luteal phase estradiol for ovarian stimulation. The study inhibited a precocious liberation of the luteinizing hormone (LH) by the...

  • Direct ovarian effects and safety aspects of GnRH agonists and antagonists. Tarlatzis, B. C.; Kolibianakis, E. M. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p8 

    The wide application of gonadotrophin-releasing hormone (GnRH) analogues in assisted reproduction has raised concerns about their potential extra-pituitary actions. Although data from animal studies support the presence of ovarian GnRH receptors and of direct ovarian effects of GnRH analogues,...

  • Duration of Stimulation is Shorter with GnRH Antagonist for Poor Responders.  // Fertility Weekly;2/20/2012, p8 

    The article reports on the study conducted by D. Pu and colleagues which evaluates the efficacy of luteinizing hormone releasing hormone antagonist (GnRH-ant) versus GnRh agonist (GnRH-a) protocols for ovarian stimulation in poor responders of in vitro fertilization (IVF). The researchers...

  • Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial. D. Bodri; V. Vernaeve; J.J. Guillén; R. Vidal; F. Figueras; O. Coll // Human Reproduction;Sep2006, Vol. 21 Issue 9, p2246 

    BACKGROUND: Little information is available on the outcome of controlled ovarian hyperstimulation (COH) using GnRH antagonist in oocyte donation cycles especially in comparison with the short GnRH agonist protocol. This study was aimed at comparing the two stimulation protocols in oocyte...

  • Comparison of GnRH agonists and antagonists in the outcome of IVF/ICSI in women with polycystic ovary syndrome. Zeinalzadeh, M.; Norani, N.; Esmaeilzadeh, S.; Yousefniapasha, Y.; Firoozpour, M.; Khafri, S. // Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p58 

    Introduction: To compare the outcome of using gonadotropin-releasing hormone (GnRH) antagonists versus agonists in women with polycystic ovary syndrome (PCOS) who underwent controlled ovarian hyper stimulation (COH) for assisted reproductive techniques (ART). Materials and Methods: A total of...

  • Comparison of GnRH antagonist versus GnRH agonist on ART outcomes in patients with poor ovarian response. Zeinalzadeh, M.; Yousefniapasha, Y.; Jorsaray, G.; Firoozpour, M. // Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p58 

    Introduction: Studies revealed that 9-24% of women who underwent ovarian stimulation induced by gonadotropins for infertility treatment represented weak ovulatory responses. The aim of the study was to compare IVF outcomes in poor-responder patients undergoing GnRH agonist protocol versus...

  • GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran. Tebraninejad, Ensieh; Ghahghaei Nezamabadi, Akrain; Rashidi, Balool; Sohrabi, Maryam; Bagheri, Maiyam; Haghollahi, Fedyeh; Nekoo, Elham Azimi; Jafarabadi, Mina // Iranian Journal of Reproductive Medicine;Summer2011, Vol. 9 Issue 3, p171 

    Background: General concern is that the pregnancy rate is higher with GnRH-agonist as a protocol of pituitary suppression. GnRH-antagonist protocol provides a shorter period of administration and an easy flexible protocol. Objective: In this study, the outcomes of GnRH agonist and antagonist in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics